Board of Directors

• hi-res version (JPG) 1.48Mb
• Version 2 (JPG) 925k
• Version 3 (JPG) 401k
• Version 4 (JPG) 461k

Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He is a member of the Board and Corporate Executive Team. Andrew joined Glaxo in 1985 and held a variety of Sales and Marketing roles in the UK business.

He has worked in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields and has been involved in multiple new product development programmes.

He has also worked in South Africa, The USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore Andrew was a Board Member of the Singapore Economic Development Board, the Singapore Land Authority and in 2003 he was awarded the Public Service Medal by the Government of Singapore.

In 2003 Andrew was appointed President of GSK Europe, and joined GSK’s Corporate Executive Team. He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List.

Andrew has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he is currently a member of the Prime Minister’s Business Advisory Group and is the Lead Non-Executive Director for the Department for Business. Andrew is President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), a position he took up on 1 January 2010. He was a Board Member of the INSEAD Business School until January 2012.

Andrew has a Joint Honours BA in Economics from the University of Nottingham.